EXTENSIVE-STAGE SMALL-CELL LUNG CANCER
Clinical trials for EXTENSIVE-STAGE SMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVE-STAGE SMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for EXTENSIVE-STAGE SMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for aggressive lung cancer
Disease control CompletedThis study tested whether adding the drug HLX10 to standard chemotherapy helps people with a type of advanced lung cancer (extensive-stage small cell lung cancer) live longer. About 585 people who had not yet been treated for this cancer took part. Half received HLX10 plus chemo,…
Matched conditions: EXTENSIVE-STAGE SMALL-CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New combo therapy shows promise for aggressive lung cancer
Disease control CompletedThis study tested whether adding an experimental drug (BMS-986012) to standard chemotherapy and immunotherapy could help people with advanced small cell lung cancer live longer without their cancer growing. The trial involved 135 newly diagnosed patients. Researchers measured saf…
Matched conditions: EXTENSIVE-STAGE SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Real-World check: does zepzelca help advanced lung cancer patients?
Disease control CompletedThis study followed 272 adults with extensive-stage small cell lung cancer who were taking the drug Zepzelca. Researchers wanted to see how well the drug worked and how safe it was in real-world settings, not just in controlled trials. The goal was to measure tumor shrinkage, sur…
Matched conditions: EXTENSIVE-STAGE SMALL-CELL LUNG CANCER
Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC
-
New combo vaccine shows promise in halting aggressive lung cancer
Disease control CompletedThis study tested a maintenance treatment for people with extensive-stage small cell lung cancer, a fast-growing cancer. After standard chemotherapy and an immunotherapy drug, patients received a personalized vaccine made from their own immune cells, plus continued immunotherapy.…
Matched conditions: EXTENSIVE-STAGE SMALL-CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Instituto Oncológico Dr Rosell • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC
-
Team nursing approach shows promise for lung cancer patients on immunotherapy
Symptom relief CompletedThis study tested a team-based nursing program for 200 people with advanced small cell lung cancer receiving chemotherapy plus immunotherapy. The program included close monitoring for side effects, help with medication adherence, nutrition and exercise support, and psychological …
Matched conditions: EXTENSIVE-STAGE SMALL-CELL LUNG CANCER
Phase: NA • Sponsor: Shanxi Province Cancer Hospital • Aim: Symptom relief
Last updated Jun 11, 2026 12:11 UTC